Search results for "genotype"

showing 10 items of 1725 documents

The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis

2015

Background & Aims Uncoupling protein 2 - UCP2 - regulates mitochondrial lipid fluxes and reactive oxygen species production by the respiratory chain. The −866 G>A UCP2 promoter region polymorphism has been linked to insulin resistance and lipid metabolism. The aim of this study was to assess whether the −866 G>A UCP2 polymorphism predisposes to nonalcoholic steatohepatitis in patients at risk, and the relationship with lipid metabolism and hepatic UCP2 expression. Methods We considered 688 Italian patients who underwent liver biopsy for suspected NASH, and 232 healthy controls. The UCP2 −866 G>A polymorphism was determined by allele specific oligonucleotide probes, hepatic UCP2 mRNA levels …

AdultMalemedicine.medical_specialtyGenotypeRespiratory chainGene ExpressionBiologyIon ChannelsMitochondrial Proteinsgenetic polymorphism; lipid metabolism;liver; mitochondria; nonalcoholic steatohepatitis; uncoupling protein-2Insulin resistanceNon-alcoholic Fatty Liver DiseaseRisk FactorsDiabetes mellitusInternal medicineGenotypemedicineHumansUncoupling Protein 2Promoter Regions GeneticUncoupling protein-2AllelesAgedPolymorphism GeneticGenetic polymorphismmedicine.diagnostic_testHepatologyLipid metabolismMiddle Agedmedicine.diseaseImpaired fasting glucoseMitochondriaEndocrinologyLogistic ModelsLipid metabolismLiverLiver biopsyCase-Control StudiesFemaleSteatosisInsulin ResistanceNonalcoholic steatohepatiti
researchProduct

Adrenomedullin and arterial stiffness: integrative approach combining monocyte ADM expression, plasma MR-Pro-ADM, and genome-wide association study.

2014

Background— Adrenomedullin (ADM) is a circulating vasoactive peptide involved in vascular homeostasis and endothelial function. Single nucleotide polymorphisms of the ADM gene are associated with blood pressure variability, and elevated levels of plasma midregional proadrenomedullin (MR-pro-ADM) are associated with cardiovascular diseases. Methods and Results— We investigated the sources of variability of ADM gene expression and plasma MR-pro-ADM concentrations in the general population, and their relationship with markers of atherosclerosis. MR-pro-ADM levels were assessed in 4155 individuals who underwent evaluation of carotid intima-media thickness and arterial rigidity (reflection inde…

AdultMalemedicine.medical_specialtyGenotypeTranscription Geneticmedicine.drug_classPopulationGenome-wide association studySingle-nucleotide polymorphismBiologyCarotid Intima-Media ThicknessPolymorphism Single NucleotideMonocytesArticleCohort Studieschemistry.chemical_compoundAdrenomedullinVascular StiffnessInternal medicineGene expressionGeneticsmedicineNatriuretic peptideHumansProtein PrecursorseducationGenetics (clinical)AgedCreatinineeducation.field_of_studyGene Expression ProfilingGenetic VariationMiddle Agedmedicine.diseaseAtherosclerosisAdrenomedullinEndocrinologyCarotid ArterieschemistryGene Expression RegulationArterial stiffnessLinear ModelsFemaleCardiology and Cardiovascular MedicineTranscriptomeGenome-Wide Association StudyCirculation. Cardiovascular genetics
researchProduct

Identification of glyoxalase 1 polymorphisms associated with enzyme activity.

2013

The glyoxalase system and its main enzyme, glyoxalase 1 (GLO1), protect cells from advanced glycation end products (AGEs), such as methylglyoxal (MG) and other reactive dicarbonyls, the formation of which is increased in diabetes patients as a result of excessive glycolysis. MG is partly responsible for harmful protein alterations in living cells, notably in neurons, leading to their dysfunction, and recent studies have shown a negative correlation between GLO1 expression and tissue damage. Neuronal dysfunction is a common diabetes complication due to elevated blood sugar levels, leading to high levels of AGEs. The aim of our study was to determine whether single nucleotide polymorphisms (S…

AdultMalemedicine.medical_specialtyGenotypeType 2 diabetesPolymorphism Single Nucleotidechemistry.chemical_compoundEnzyme activatorLactoylglutathione lyaseInternal medicineDiabetes mellitusGeneticsmedicineHumansAllelesGeneticsType 1 diabetesbiologyMethylglyoxalLactoylglutathione LyaseGeneral MedicineMiddle Agedmedicine.diseaseEnzyme assayEnzyme ActivationEndocrinologyDiabetes Mellitus Type 1chemistryDiabetes Mellitus Type 2biology.proteinFemaleGlyoxalase systemGene
researchProduct

Association between M467T and 114 C--A variants within the SLC3A1 gene and some phenotypical traits in cystinuria patients from Spain.

2000

Cystinuria is an inherited metabolic disease characterized by an abnormal urinary excretion of cystine and dibasic amino acids. Formation of renal calculi, recurrent infections and renal failure are the main complications of this disease. The SLC3A1 gene, which codes for a dibasic amino acid transporter protein, is involved in the pathogenesis of cystinuria. We investigated the possible association between molecular variants (M467T, E483X, T216 M and 114 C--A) within the SLC3A1 gene and some phenotypical traits in a Spanish area. The study population consisted of 45 cystinuria patients, 42 cystinuria relatives and 81 healthy control subjects. Only the M467T mutation was found in chromosomes…

AdultMalemedicine.medical_specialtyGenotypeUrinary systemCystineBiologychemistry.chemical_compoundKidney CalculiSex FactorsMale Urogenital DiseasesInternal medicineGenotypeGeneticsmedicineHumansAlleleAmino AcidsChildAllele frequencyGenetics (clinical)AllelesCystinuriaMembrane GlycoproteinsPolymorphism GeneticMediterranean RegionAge FactorsCystinuriamedicine.diseaseFemale Urogenital DiseasesEndocrinologyPhenotypechemistrySpainAminoaciduriaMutationPopulation studyAmino Acid Transport Systems BasicRegression AnalysisFemaleCarrier ProteinsHuman genetics
researchProduct

Role of Toll-like receptor 4 in acute myocardial infarction and longevity.

2004

AdultMalemedicine.medical_specialtyGenotypemedia_common.quotation_subjectLongevityMyocardial InfarctionMEDLINEReceptors Cell SurfaceBioinformaticsPolymorphism Single NucleotideInternal medicineGenotypemedicineHumansMyocardial infarctionReceptorAgedmedia_commonAged 80 and overToll-like receptorMembrane Glycoproteinsbusiness.industryToll-Like ReceptorsLongevityGeneral MedicineMiddle Agedmedicine.diseaseToll-Like Receptor 4Cardiologybusiness
researchProduct

Dopamine D4 receptor exon III polymorphism, adverse life events and personality traits in a nonclinical German adult sample.

2010

Personality and temperament embrace a wide area of both psychological and behavioral processes which are also based on disposition. A functional polymorphism in exon III of the dopamine D4 receptor gene (DRD4) has been a highly suspect genetic marker for personality in spite of ambiguous results. The present study aimed to further elucidate the relationship between DRD4, negative life events and personality in a representative nonclinical sample. Hundred sixty-seven Germans completed the NEO Five-Factor Inventory, the Tridimensional Personality Questionnaire and the California Adult Q-Sort. A factor analysis revealed 3 factors: emotional stability, social orientation and impulsivity. DNA fr…

AdultMalemedicine.medical_specialtyGenotypemedia_common.quotation_subjectMedizinische Fakultät -ohne weitere Spezifikation--Minisatellite RepeatsImpulsivityPersonality AssessmentWhite PeopleTridimensional Personality QuestionnaireLife Change EventsGermanymental disordersmedicinePersonalityHumansddc:610AlleleBig Five personality traitsPsychiatryBiological PsychiatryAllelesmedia_commonSex CharacteristicsPolymorphism GeneticReceptors Dopamine D4ExonsMiddle AgedPsychiatry and Mental healthNeuropsychology and Physiological PsychologyTemperamentFemalemedicine.symptomPersonality Assessment InventoryPsychologyClinical psychologySex characteristicsPersonalityNeuropsychobiology
researchProduct

Combined treatment of relapse of chronic hepatitis C with high-dose α2b interferon plus ribavirin for 6 or 12 months

2000

Abstract Background/Aims: Retreatment of relapses of chronic hepatitis C with a standard regimen of interferon plus ribavirin for 6 months obtains a sustained response in a minority of patients with high viraemia and genotype 1b . We aimed to assess whether increasing the interferon dose and prolonging the time of combined treatment may enhance the effectiveness, and also to evaluate the tolerability, and to identify the determinants of sustained response. Methods: Fifty subjects with chronic hepatitis C who had relapsed after one or more courses of α-interferon monotherapy were randomised to receive α 2 b interferon (6 MU tiw) plus ribavirin (1000–1200 mg daily) for 6 or 12 months. ALT nor…

AdultMalemedicine.medical_specialtyGenotypemedicine.medical_treatmentAlpha interferonHepacivirusInterferon alpha-2Antiviral AgentsGastroenterologyDrug Administration Schedulechemistry.chemical_compoundRecurrenceInterferonInternal medicineRibavirinmedicineHumansInterferon alfaChemotherapyDose-Response Relationship DrugHepatologybusiness.industryRibavirinInterferon-alphaHepatitis C ChronicMiddle AgedRecombinant ProteinsAnti-Bacterial AgentsSurgeryRegimenTreatment OutcomechemistryTolerabilityRNA ViralDrug Therapy CombinationFemaleComplicationbusinessmedicine.drugJournal of Hepatology
researchProduct

Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-alph…

2003

Ageing is associated with chronic, low grade inflammatory activity leading to long term tissue damage, and systemic chronic inflammation has been found to be related to mortality risk from all causes in older persons.1 Also, the genetic constitution of the organism interacting with systemic inflammation may cause defined organ specific illnesses. Thus, age related diseases such as Alzheimer’s disease (AD), Parkinson’s disease, atherosclerosis, type 2 diabetes, sarcopenia, and osteoporosis, are initiated or worsened by systemic inflammation, suggesting the critical importance of unregulated systemic inflammation in the shortening of survival in humans.1–3 Accordingly, proinflammatory cytokin…

AdultMalemedicine.medical_specialtyGenotypemedicine.medical_treatmentDNA Mutational AnalysisLongevityInflammationSingle-nucleotide polymorphismBiologySystemic inflammationPolymorphism Single NucleotideProinflammatory cytokineGene FrequencyInternal medicineGeneticsmedicineHumansAllelePromoter Regions GeneticGenetics (clinical)AgedGeneticsAged 80 and overInflammationTumor Necrosis Factor-alphaAge FactorsDNAMiddle AgedInterleukin-10Interleukin 10CytokineEndocrinologyImmunologyFemalemedicine.symptomCentenarianLetter to JMGJournal of medical genetics
researchProduct

Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction.

2007

. Objective.  Resistin is an adipokine that has been suggested to be correlated with markers of inflammation and to be predictive of coronary atherosclerosis and type II diabetes in humans. A common single nucleotide polymorphism (SNP) (−420C/G) in the promoter of resistin is associated with increased resistin plasma levels and susceptibility to type II diabetes. The aim of this study was to investigate the association of the -420C/G polymorphism with metabolic syndrome, obesity, myocardial infarction and kidney disease. Design and results.  First we studied 1542 subjects from the PLIC study (a population based cohort). GG carriers showed an higher prevalence of obesity and metabolic syndro…

AdultMalemedicine.medical_specialtyHeart diseaseGenotypeMyocardial InfarctionAdipokineGene ExpressionSingle-nucleotide polymorphismPolymorphism Single NucleotideCohort StudiesInternal medicineInternal MedicinemedicineHumansGenetic Predisposition to DiseaseResistinMyocardial infarctionObesityRNA MessengerPromoter Regions GeneticAgedMetabolic SyndromeFramingham Risk Scorebusiness.industryMiddle Agedmedicine.diseaseLipidsEndocrinologyKidney dysfunction metabolic syndrome myocardial infarction PBMC resistins SNPChronic DiseaseResistinFemaleKidney DiseasesMetabolic syndromebusinessKidney diseaseJournal of internal medicine
researchProduct

Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia.

2008

Aim To evaluate the reliability of the bright liver (BL) echo pattern on ultrasound to detect histological steatosis in chronic cryptogenic hypertransaminasaemia (CCH) and hepatitis C virus (HCV)-related forms of hypertransaminasaemia. Materials and methods One hundred and fifty patients, 54 with CCH and 96 with HCV hypertransaminasaemia (76 genotype 1/2 and 20 genotype 3), were enrolled. Histological steatosis was measured as the percentage of hepatocytes involved. The reliability of the BL sign was estimated using the sensitivity, specificity, positive and negative predictive values. Results Histological steatosis was present in 102/150 patients (68%) divided into 59/96 (62%) in the HCV g…

AdultMalemedicine.medical_specialtyHepatitis C virusHepacivirusmedicine.disease_causeGastroenterologySensitivity and SpecificityInternal medicineStatistical significanceGenotypemedicinePrevalenceHumansRadiology Nuclear Medicine and imagingProspective StudiesUltrasonography Doppler ColorTransaminasesHepatitis Chronicbiologybusiness.industryFatty liverGeneral MedicineHepatitis CMiddle Agedmedicine.diseasebiology.organism_classificationHepatitis CConfidence intervalFatty LiverItalyLiverHepatocytesFemalebright liver ultrasound steatosis cryptogenic hypertransaminasaemiaSteatosisbusinessBiomarkersClinical radiology
researchProduct